1. Supporting Information:
One of Pfizer’s many initiatives is continuous improvement (CI). Whilst in the UK, I worked on 3 major projects
that were all part of the CI initiative.
The first two projects were set-up within Safety & Risk Management, where the focus was to speed up the
conducting of quality control of large safety documents.
 As part of a CI project over a year period, we were able to identify what areas within these documents had the
most findings. This was a proactive project as we could see the benefits of that it would speed up the overall
submission times.
These findings were submitted to management and from there it was agreed to only target those areas of the
documents that were of high risk and high profile. Thus going form a 100% quality control of a document, it
became 40 %, with more ownership being place on the authors of the documents to get the documents right first
time.
 I was assigned my second continuous improvement project, where I had to attend meetings held in New York
during 2004, as my manager was able to utilize my skills and experience to foster good working relations ships
with our colleagues in the US. I assisted with the Global Quality Redesign process with the aim of continuous
improvement and attended four, weekly meetings over the whole year. This was an excellent opportunity for
networking with my global colleagues during the Global Quality Redesign meetings and enhanced relationships
with my colleagues in the US. I was able to forge strong working relations with colleagues and customers.
The outcome of the project was the development of new software called AQUA (Application for Quality Analysis)
which was a web-based system that allowed for global load-sharing and extension of the workday. It enabled
electronic capture of quality observations and allowed for trending of data.
In addition, I designed, developed and produced the development day posters (see below). These posters and
eye catching displays were later shown at a global road-show in the U.S.
 In 2008, my third CI project was part of a Global continuous improvement initiative, where we successfully
completed the SOP Remediation project. I worked with my colleagues in the US in harmonising document naming
convention for documentation within our Global repository; and assisting with the Pharmaceutical Sciences
Procedure Strategy - which was designed to minimise the number of local SOPs at each site – known as SOP
Remediation. The aim of the strategy was to standardise the Global processes; over half of the SOPs became
Standard Operating Instructions (SOIs). The balance were incorporated into global procedures or obsoleted
Due to my involvement with this project I was able to ensure good working relationship with colleagues at all
levels, from front line staff, those leading the project to those administrators in the UK, India and the US, a
sharing of information between sites, various sub-project teams were also involved for which I had to coordinate
to ensure a smooth running of the project and that all senior management were regularly informed of progress
and timelines. I believe I can draw on these experiences and apply them with positive effect.
Pfizer Science jamboree
From 2002 to 2008 I was actively involved in the Pfizer Science jamboree. I helped create posters, display stalls
and organised the volunteers. One of these posters for the jamboree was to create a colourful and easy to follow
process map of the drug development process from the start of when the molecule was discovered up until it is
then marketed. This was Pfizer’s 15th successive jamboree attracting 1920 children from more than 45 primary
and special schools.
Both the development day and science jamboree events were captured in local intranet stories raising the
awareness of such systems and Pfizer’s commitment to the community.